Press releaseGlobe Newswire
Cogent Biosciences
COGT · NASDAQ
$31.24+$1.23 (+4.10%)TodayMarket closed ·
Prev close $30.01
Latest news
- News
Cogent Biosciences Enters Commercial Supply Agreement With Hovione On Sept 1, 2026; To Purchase Minimum Percentages Of Bezuclastinib Products From Hovione; Agreement Effective For Five-Year Term With Automatic Two-Year Renewals
- Press releaseGlobe Newswire
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
- NewsVandana Singh
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application
- Press releaseGlobe Newswire
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
- NewsKaustubh Bagalkote
Why Is Pfizer Stock Rising Tuesday?
- Press releaseGlobe Newswire
Cogent Biosciences Announces Pricing of Concurrent Public Offerings of Common Stock and 1.625% Convertible Senior Notes Due 2031
- Press releaseGlobe Newswire
Cogent Biosciences Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsAvi Kapoor
Gold Jumps Over 2%; Dole Shares Gain After Q3 Results
- NewsAvi Kapoor
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday
- NewsAvi Kapoor
S&P 500 Surges 1%; Tyson Foods Posts Upbeat Earnings
- Press releaseGlobe Newswire
Cogent Biosciences Reports Positive Results from Bezuclastinib PEAK Phase 3 Trial in Gastrointestinal Stromal Tumors (GIST)
- NewsAvi Kapoor
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
- Press releaseGlobe Newswire
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
- Press releaseGlobe Newswire
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
- NewsVandana Singh
Cogent's Chronic Immune Disorder Drug Has Strong Potential To Become A Blockbuster: Analyst
- NewsRishabh Mishra
US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns'
- NewsAvi Kapoor
Trump Tariffs Sink Dow Over 400 Points: Investor Sentiment Declines, But Fear & Greed Index Remains In 'Extreme Greed' Zone
- NewsAvi Kapoor
Dow Dips 1%; Mustang Bio Shares Spike Higher
- NewsAvi Kapoor
KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday
- News
Market-Moving News for July 7th
- NewsAvi Kapoor
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.